Kursprognose für Eloxx Pharmaceuticals Inc (ELOX)ELOXEloxx Pharmaceuticals Inc

Alphio's ELOX stock price prediction model matches the current Eloxx Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $12.46 (+0.19%). The 1-week path is $12.76 (+2.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Eloxx Pharmaceuticals is currently not a strong buy due to its recent financial performance and technical indicators. The stock price is at $12.84, which is significantly below its 52-week high of $23.40, indicating a potential for recovery but also a risk of further decline. The RSI is at 39.31, suggesting that the stock is nearing oversold territory, but the recent 5-day change is down 2.51%, reflecting ongoing bearish sentiment. The company reported a net loss of $4.5 million in Q2 2026, which is a 137.5% increase in losses compared to the previous year, raising concerns about its profitability. However, the completion of a $66 million public offering and FDA clearance for a Phase 2 clinical trial could provide positive catalysts for future growth. The main risk is the ongoing losses, which have increased significantly, and the current ratio of 3.74 indicates a strong liquidity position but does not guarantee profitability in the near term.

Eloxx Pharmaceuticals Inc (ELOX) last closed at $12.4399996, losing -2.81%. These facts feed the 1-day and 1-week ELOX price prediction above.